JP Morgan Chase
NPSP

JP Morgan Chase’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

JP Morgan Chase’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-328,744
Closed -$11.8M – 4463
2014
Q4 		$11.8M Sell
328,744
-98,864
-23% -$2.95M ﹤0.01% 1837
2014
Q3 		$11.1M Buy
427,608
+45,767
+12% +$1.31M ﹤0.01% 1838
2014
Q2 		$12.6M Sell
381,841
-452,496
-54% -$13.1M ﹤0.01% 1616
2014
Q1 		$25M Sell
834,337
-49,875
-6% -$1.72M 0.01% 1201
2013
Q4 		$26.8M Buy
884,212
+448,495
+103% +$12.4M 0.01% 1157
2013
Q3 		$13.9M Buy
435,717
+29,591
+7% +$679K ﹤0.01% 1544
2013
Q2 		$6.14M Buy
+406,126
New +$5.63M ﹤0.01% 1995

Other funds holding NPSP

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

JP Morgan Chase's NPSP Position: Q1 2015 in Review

JP Morgan Chase sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 328,744 shares — an estimated $11.8M sold.

JP Morgan Chase first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $26.8M in Q4 2013. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • JP Morgan Chase reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • JP Morgan Chase sold 328,744 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $11.8M.
  • JP Morgan Chase first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • JP Morgan Chase's NPS PHARMACEUTICALS INC position peaked at $26.8M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.